Results 211 to 220 of about 135,129 (369)
Expression of the CXCR4 S338X Variant Improves Anti‐Leukemia Efficacy of Anti‐CD19 CAR‐T Cells
Under normal conditions, CXCL12 stimulation induces CXCR4 degradation. In contrast, CAR19‐T cells expressing the CXCR4 S338X variant maintain receptor stability and sustain ERK and AKT signaling, which supports T‐cell effector function, migration, and survival. Therefore, the enhanced anti‐leukemic activity is conferred by CXCR4 S338X expression in CAR‐
Yushu Mao +12 more
wiley +1 more source
The association of clathrin fragments with coated vesicle membranes.
Manjit Hanspal +2 more
openalex +1 more source
Heat shock proteins at the crossroads of endosomal trafficking pathways. [PDF]
Zuppini F +4 more
europepmc +1 more source
Nanosilicates triggered MAP4‐dependent microtubule remodelling via the ROS/MAPK pathway, shifting microtubules into a dynamic active state, which subsequently promoted activation of the STAT3 pathway, ultimately facilitating periodontal angiogenesis.
Lingling Shang, Yuhan Hu, Shaohua Ge
wiley +1 more source
Modulation of host cell pathways by <i>Coxiella burnetii</i> Dot/Icm effectors. [PDF]
Yuan J, Zhang Y, Song L, Luo ZQ.
europepmc +1 more source
Identification of Suppressor of Clathrin Deficiency-1 (SCD1) and Its Connection to Clathrin-Mediated Endocytosis inSaccharomyces cerevisiae [PDF]
Balaji T. Moorthy +4 more
openalex +1 more source
LMPt enters the cell mainly through caveolin‐mediated endocytosis, and then fuses with endosomes and lysosomes to deliver MPt to mitochondria and the endoplasmic reticulum to induce mitophagy based on the fusion of lysosomes and mitochondria, and endoplasmic reticulum stress and subsequent apoptosis via the Bip–PERK–eIF2α–ATF4 axis to exert an anti ...
Cong Zhao +9 more
wiley +1 more source
Brain-specific clathrin light chain LCb exists in cl athrin-coated vesicles of neuronal origin
Toshiko Uriu +3 more
openalex +1 more source
Abstract Aims/Hypothesis Pancreatic beta‐cell dysfunction is pivotal in diabetes pathogenesis, with the NOD‐like receptor protein 3 (NLRP3) inflammasome playing a crucial role. Dapansutrile (DAPA), a novel NLRP3 inhibitor, demonstrates promise in diabetes management.
Ying Wu +6 more
wiley +1 more source

